CarolJoanLevyMD

Endocrinology • New York, NY

Diabetes, Lipid Metabolism

Associate Professor, Medicine, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Levy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levy's full profile

Already have an account?

Office
5 E 98th St
New York, NY 10029
Phone+1 212-241-3422

Fax+1 212-423-0508

Education & Training

Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1988 - 1992
Northwestern University The Feinberg School of MedicineClass of 1988

Certifications & Licensure

FL State Medical License 2020 - Present
NY State Medical License 1995 - 2026
MA State Medical License 1991 - 2000
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Start of enrollment: 2014 Feb 01
Completed
Phase 3
USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes Start of enrollment: 2014 Jun 01
Completed
Not Applicable
Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes Start of enrollment: 2017 Apr 17
Completed
Not Applicable

Publications & Presentations

PubMed

176 citations
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Richard E. Pratley, Lauren Kanapka, Michael R. Rickels, Andrew J. Ahmann, Grazia Aleppo
JAMA. 2020-06-16
2 citations
All Children Deserve to Be Safe, Mothers Too: Evidence and Rationale Supporting Continuous Glucose Monitoring Use in Gestational Diabetes Within the Medicaid Population.
Carol J Levy, Rodolfo J Galindo, Christopher G Parkin, Jacob Gillis, Nicholas B Argento
Journal of Diabetes Science and Technology. 2024-09-01
2 citations
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes.
Nagesha Guthalu Kondegowda, Joanna Filipowska, Jeong-Su Do, Nancy Leon-Rivera, Rosemary Li
Science Advances. 2023-11-03

Press Mentions

Tandem Backs Use of Insulin PumpNovember 15th, 2022
Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ TechnologyNovember 10th, 2022
JDRF Recognizes Mount Sinai’s Contribution to Diabetes Research and Patient CareApril 30th, 2022
Join now to see all